Powder Delivery TRIZ Cases

A copolymer with trialkoxysilyl side chains forms stable nanoparticles that encapsulate physiologically active substances.

Adjusting peptide charge via isoelectric point modification reduces burst release and improves encapsulation efficiency in polymer delivery systems.

Lactobacillus plantarum GKM3 increases Cisd2 gene expression to reduce mitochondrial damage, delaying nerve degeneration and sarcopenia.

Ceria nanocomposite with polyethylene glycol coating addresses acute brain damage from extravasated blood by reducing oxidative stress and inflammation.

Solvent-free wet milling reduces benzoyl peroxide particle size below 25 microns, eliminating skin irritation from large crystals and chemical residues.

Coating elemental bismuth cores prevents oxidative degradation and bioaccumulation, offering a safer alternative to gold nanoparticles.

A dry powder inhaler uses alternating mesh networks to collide with drug particles and separate active ingredients from carriers.

Live non-pathogenic fecal bacteria restore balanced gut microbiota, resolving recurrent diverticulitis without complex conventional regimens.

Texaphyrin-phospholipid conjugates self-assemble into nanoparticles to resolve non-specific toxicity and solubility issues in cancer therapy.

A bortezomib and boric acid solid composition stabilizes the active pharmaceutical ingredient through boronate ester formation.

STICK nanoparticles use maltobionic acid and 4-carboxyphenylboronic acid for sequential targeting across the blood-brain barrier.

Nutritional supplement replenishes water-soluble vitamins and minerals lost during dialysis, preventing fat-soluble vitamin accumulation toxicity.

High moisture oral compositions balance sensory attributes with product stability through controlled filler and active ingredient ratios.

Spontaneous zein nanoparticle formation via non-volatile solvents eliminates volatile solvent removal steps, enabling scalable industrial production.

Sphingomyelin liposomes transport hydrophilic therapeutic agents directly to bladder tissue.

Inhalation aerosols bypass gastrointestinal intolerance and first-pass metabolism to treat chemotherapy-induced nausea.

Segmented amphetamine beads combine immediate and enteric coatings to deliver pulsed drug release profiles.

PEGylation and nanoparticle encapsulation resolve poor solubility of hydrophobic triterpenes, increasing bioavailability while reducing systemic toxicity.

Polyester-polyamine blends boost immune activation efficacy by resolving the trade-off between manufacturing simplicity and ligand density.

Perpendicular turbulent mixing of aqueous RNA and ethanol lipid streams yields bilayer nanoparticles with uniform size distribution.

Optimized roller displacement and spout positioning reduce volume deviations to enable precise dosing of 1000 µl pharmaceutical units.

An oral composition delivers fatty acids to the gastrointestinal tract to induce satiety and manage weight.

Self-emulsifying glycerolipid formulations enhance bioavailability by bypassing hepatic metabolism and reducing membrane irritation.

Pegylated carfilzomib compounds extend plasma half-life through polymer conjugation, reducing dosing frequency from twice weekly to once weekly.

Hot melt extrusion creates antibody filaments with trehalose to maintain stability during processing.

HIF-2α inhibitors reverse obliterative vascular remodeling and improve survival in pulmonary arterial hypertension models.

Biocompatible polymer shells isolate toxic cerium oxide nanoparticles, allowing reactive oxygen species diffusion to scavenge radicals and monitor inflammation.

HA-EDA-MA hydrogels enable sustained enzyme release in gastrointestinal fluids, reducing administration frequency for celiac disease treatment.

A magnetic nanoparticle core integrates fluorophores and chelating compounds to serve as a unified contrast platform.

Phase-separated polymer compositions combine distinct thermal transition phases to deliver fracture and fatigue toughness in medical devices.

Cancer-specific promoter nucleic acid constructs deliver therapeutic agents to tumors, reducing systemic toxicity while maintaining anti-cancer activity.

Ionizable cationic lipid nanoparticles encapsulate nucleic acids, reducing immune response and toxicity while maintaining cell viability.

Solid decellularized cardiac tissue microparticles extend retention and stiffness compared to liquid hydrogels, reducing left ventricular remodeling.

A topical composition blends egg yolk with burned cereal powder to form a protective crust on injured tissue.

A nanoparticulate metal oxide core coated with a phosphorylated polyol shell containing hydrophilic ether moieties.

Solid shaped masses preserve protein bioactivity during compression, enabling oral delivery of sensitive therapeutics.

Triplex-forming oligonucleotides bind amplified HER2 DNA to trigger p53-independent apoptosis, overcoming resistance in aggressive cancers.

Activity-based probes amplify CT signals by attaching multiple iodine moieties to enzyme-interacting carriers, resolving low sensitivity in protease detection.

A polymeric microparticle with a gas core and photoacoustic shell enables simultaneous ultrasound and photoacoustic imaging.

Segmented micro-particles inside a degradable tube eliminate time lag before drug delivery.

Polymeric complexing agents bind hypericin sodium salt to enhance stability and selective tumor accumulation.

TFG nanoparticles normalize tumor vasculature and alleviate hypoxia, converting harmful conditions into enhanced treatment sensitivity.

Co-crystallization of niraparib tosylate with urea or oxalic acid improves solubility while reducing static charge to resolve flowability bottlenecks.

Segmenting enzymes into recognition and catalytic components reduces side effects while extending stability in the circulatory system.

A pharmaceutical composition using mixed root extracts to recover mitochondrial function and protect dopaminergic neurons.